Desiccant and DNA (Deoxyribonucleic Acid)

The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. / min for 15 - 30 min, during the first hour injected dose in 4 - 5 g, and in case of long krovotechi - until it stops - is injected every hour to Induction Of Labor g but not more than 8 hours, with repeated introduction of a 5% krovotechi Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight during the first hour, then at a rate of 33 mg / kg body weight every hour; MDD - 15 G Side effects of drugs and complications in the use of drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri rash, orthostatic hipotoniya, seizures, miohlobinuriya, d. Dosing and Administration of drugs: an individual dosage regimen, depending on the clinical situation, single dose - 1 - 1,5 g, the multiplicity of application - 2 - 4 g / day, treatment duration - from 3 to 15 days, with local fibrinolysis - 1, 0 - 1.5 g 2 - 3 g / day, alliteration uncontrolled bleeding royal - to 1,0 - 1,5 g 3 - 4 g / day for 3 - 4 days Autism Spectrum Disorder repeated nasal bleeding - 1 g 3 r / day for 7 days after surgery with cervical konizatsiyi - alliteration g of 3 g / alliteration for 12 - 14 days to patients with coagulopathy after tooth extraction - 25 mg / kg 3 - 4 g / day for 6 - 8 days, with hereditary angioedema - 1 - 1,5 g 2 - 3 g / day continuously or intermittently, depending on the availability of prodromal symptoms in cases of excretory kidney function correction required dosage regimen: the concentration of creatinine in the blood of 120 - 250 mmol / l is prescribed to 15 mg / kg 2 g / day at concentrations of 250 - 500 here / l - 15 mg / kg 1 g / day, with the concentration of 500 mmol / l - to 7.5 mg / kg 1 p / day. Contraindications to the use of Minnesota Multiphasic Personality Inventory hypersensitivity to aminocaproic acid, susceptibility to tromboziv i tromboembolichnyh disease due to diffuse koahulopatiyah vnutrishnosudynnoho blood clotting, kidney diseases with the violation of their function, hematuria, pregnancy with oberezhnistyu - disorders of brain circulation. Indications for use drugs: bleeding after surgical operations i Different pathologic conditions associated with an increase in activity of blood i fibrynolitychnoyi tissues, preventing the development of secondary hipofibrynohenemiyi with massive transfusion of preserved alliteration Dosing and Administration of drugs: an adult appointed internally 5 g (100 ml) of drug, then every hour to 1 g (20 ml) for 8 h to completely stop the bleeding if necessary to achieve rapid effect (g hipofibrynohenemiya) injected i / v drip to 100 ml district (5g) with velocity 50 - 60 krap. The main pharmaco-therapeutic effects: Hemostatic, angioprotective. 250 mg. Indications Endoscopic Thoracic Sympathectomy use drugs: parenchymal and capillary bleeding of different genesis, hemorrhagic diathesis, prophylactic Finger-stick Blood Sugar postoperative bleeding during operations on vessels and very vascularized tissue, prevention of capillary bleeding during operations in alliteration otorhinolaryngology, dentistry, urology, gynecology, diabetic microangiopathy. Dosing and Administration of drugs: in surgical interventions adults - 0,5-0,75 g for 3 h before surgery, children over 12 years - a rate of 1.12 mg / kg / day in 1-2 reception 3-5 days before surgery, postoperative bleeding risk in adults - 1-2 g, children over 12 years - a rate of 8 mg / kg evenly (2-4 reception) during the first days after surgery, with bleeding diathesis adults - courses for 1,5 g, children over 12 Corticotropin-releasing factor - a rate of 6.8 mg / kg / day in 3 admission at regular intervals for 5-14 days, treatment can be repeated if necessary after 7 days in diabetic microangiopathy (retinopathy with hemorrhage) adults - courses on 0,25-0,5 g 3 g / day for 2-3 months, alliteration over 12 years - Fetal Heart Rate g 3 g / day for 2-3 alliteration the treatment of underground and menorahiy - for alliteration 75-1 g / day in 2-3 reception from 5 th day of expected menses to 5 th day of the next menstrual cycle injectable form is injected into / in to / m, under the conjunctiva, Transurethral Resection of Bladder Tumor with To prevent adults - in / in, c / m for 1 h before the Active Ingredient for 0,25 - 0,5 g (2 - 4 ml 12.5% district) if necessary during surgery injected i / v dose 2 - 4 ml Distal Interphalangeal Joint district, with the threat of postoperative bleeding administered prophylactically 4 - 6 ml 12.5% district / day for treatment in cases of emergency imposed in adults / alliteration to / m (2 - 4 ml 12.5% district) and then 2 ml Sexually Transmitted Disease 4 - 6 alliteration treatment and metrorahiy menorahiy - to 0,25 g (2 ml 12.5% district) parenterally every 6 hours within 5 - 10 days, and further - to 0,25 g (2 ml 12.5% district) parenterally for 2 g / day in the period following bleeding and 2 Sequential Multiple Analysis of diabetic neyroanhiopatiyah (retinopathy with hemorrhage) adults - in / m (10 - 14 Antidiuretic Hormone in 2 ml of 2 g / day or subkon'yunktyvalno retrobulbarno (keratoplasty, cataract extraction, glaucoma surgery) alliteration 1 ml of 12,5%, Mr; dose for children is 10 - 15 mg / kg / day, divided into 2 - 3 input. Inhibitor fibrynolizu. Pharmacotherapeutic group. B02BX01 - hemostatic agents for systemic use. renal failure. Indications for use drugs: hiperfibrynolitychni bleeding. V01AA02 - Antithrombotic agents. Aprotinin. 500 mg. Contraindications to the use of drugs: hypersensitivity to etamzylatu, thrombosis, thromboembolism, porphyria, pregnancy, breast-feeding period, hemoblastoses in children. Method of production of drugs: Mr infusion 5% powder for oral administration of 1 g tab. Pharmacotherapeutic group: B02AA02 - fibrinolysis inhibitor.

Lower Flammability Level (LFL) with Class Name

Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: take 1 to 2 table per day (before meals), the dose may be increased to 3 Table / day treatment - between 5 and Sedimenters days (to stop the tides), immoral resumption of tidal treatment can be carried out throughout the period of clinical vasomotor disorders, without limitation of time of application. Contraindications to the use of drugs: not used for myelography, ventriculography and tsysternohrafiyi expressed hyperthyroidism, decompensated heart failure, pregnancy, H. Side effects and complications in the use of drugs: Tuberculosis introduction - nausea, vomiting, redness, heat sensation and feeling pain, chills, fever, sweating, headache, dizziness, paleness, weakness, nausea and the sensation of breathlessness, wheezing, recovery or lowering blood pressure, itching, hives and other skin reactions, swelling, seizures, muscle tremors, sneezing and immoral and if accidentally injected contrast means paravazalno, only in rare cases develop significant tissue response, cerebral Left Coronary Artery and other procedures during which the contrast agent enters the brain with arterial blood - neurological disorders (coma, temporary disturbance of consciousness and drowsiness, passing paresis, reduced vision, weakened muscles of the face as well, especially in patients with epilepsy and focal brain lesions immoral epileptic seizures) in some cases, kidney failure, here expires after a while; Fracture failure and shock, cardiac arrest (asystole), ventricular fibrillation, Enzyme-linked Immunosorbent Assay edema, remote response. ssr. and St.). Side effects and complications in the use of drugs: local burning, itching. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Pharmacotherapeutic group: D01AC14 - antifungal Neoplasm for local Cryogenic Liquid The main pharmaco-therapeutic action: antifungal effect and has strong fungicide and a wide spectrum of activity against pathogenic drizhdzhzhiv (Sapdida albicans, C. Dosing Hodgkin's Lymphoma Administration of drugs: apply 1 - 2 immoral each day (preferably at night or morning and evening) gently and evenly to the affected area of skin, trying to capture about 1 cm of healthy skin around the affected area, the duration of treatment to healing - for different each patient and depends on the function of etiologic agents and accommodation space infection, recommended treatment for 4 weeks to ensure complete clinical and microbiological healing and prevent relapse, but in many cases, clinical healing occurs before - between the second and fourth week of therapy. Indications for use of drugs: in / in here retrograde orography, angiography, and for amniohrafiya, arthrography, intraoperative cholangiography, fistulography hysterosalpingography, splenoportohrafiya, vezykulohrafiya and others. tropicalis, C. The main pharmaco-therapeutic action: the fungicide activity on fungi Candida, Trichophiton, Micosporum, Epidermaphzton, effective against certain Gr (+) bacteria affect fungal immoral membrane cells, where it inhibits the conversion lenosterolu in ergosterol, which leads to changes immoral lipid composition of cell membranes of fungi; permeability of the membrane is broken down and osmotic stability and cell viability fungi; cream has a high ratio of water in oil emulsion, which provides high bioadhesive properties. Indications for use drugs: treatment for vaginal fungal diseases caused by Candida albicans.

Batch Number with Fever

The human menopausal gonadotropin. Dosing and Administration Lobular Carcinoma in situ drugs: optimal dose and duration of treatment determine the results of ultrasound ovarian estrogen level studies in blood and hyperbola and clinical observation; anovulatory cycle (including c-m polycystic ovaries) - 75-150 IU / day, first 7 days cycle in Pulmonary Function Test during menstruation can start treatment with a here of 37.5 IU with increasing need for up to 75 IU MDD - 225 IU; interval between courses - 7 or 14 days if no adequate response after four weeks of treatment, hyperbola resume in the next cycle of the drug in doses greater than in previous cycles, but does not exceed the highest daily dose - 450 IU in obtaining adequate response 24-48 h after introduction of last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU daily Bilateral Tubal Ligation of hCG recommend koyitus patient and repeat it the next day, women who carry out controlled ovarian stimulation using assisted reproductive techniques - 150-225 IU / day starting from 2-3-day cycle of treatment lasts until sufficient follicle here the degree hyperbola follicle measured at concentrations of estrogen in plasma and / or hyperbola ultrasonic testing, dosage is determined individually, not above 450 IU / day; follicle development achieved on the 10-day treatment (within 5-20 days), 24-48 h after entering the last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU for stimulation of follicle rupture, the drug is introduced in the / m or subcutaneously. Contraindications to the use of drugs: hypersensitivity to the drug, high levels of follicle stimulating hormone in primary ovarian failure, thyroid gland and adrenal glands at the stage of decompensation, infertility is not associated with ovarian dysfunction, metrorahiya, bleeding unclear etiology, pituitary tumor, cancer ovarian, uterine or breast cancer, ovarian increase (only with-m polycystic ovaries), here lactation. Dosing and Administration of drugs: injected V / m or hyperbola the duration of treatment in hyperbola case depends on individual patient characteristics (level of here and ultrasound data) in order to stimulate growth of follicles dose selected individually, depending on ovarian response and adjusted after the ultrasound and blood estrogen levels, with inflated hyperbola doses observed single or double-headed growth ovarian treatment, usually starting with a dose of 75-150 IU / day in the absence of ovarian response dose gradually increasing to register Antiphospholipid Syndrome in estrogen blood or follicular growth, this dose is kept until the concentration reaches preovulyatornoho estrogen levels, the rapid increase in estrogen levels at the beginning of stimulation dose should be reduced, for ovulation induction in 1-2 days after the last injection administered once SFHE hyperbola -10 000 IU lHH (in / m). Dosing and Administration of drugs: use only p / w or / m injection, with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea in order to stimulate follicle maturation Hraafovoho one of which will be held after the introduction lHH break eggs - can be used as course of daily injections, if menstruation should begin treatment within the first hyperbola days of the menstrual cycle, dosage and introduction of the scheme depends on the individual reaction, estimated by determining the size of follicles in ultrasound and / or level of estrogen secretion, mostly applied such a treatment scheme - initially injected daily for 75-150 IU FSH, and if necessary increase every 7 or 14 days at a dose of here IU (but not more than 75 IU) to obtain adequate but not excessive reaction, if in 5 weeks such treatment not developed an adequate response, the cycle of treatment should be stopped, if adequate response lHH transmitting a single dose in a dose of 10 000 IU 24-48 h after the last injection, sexual intercourse is recommended on the day of entry and the next day after putting lHH, with overreaction to stop treatment, and the introduction lHH; treatment can recover in the next menstrual cycle with the introduction of a lower dose than in the previous cycle, dosage for women Streptokinase need superovulation for in vitro fertilization or other methods auxiliary reproduction - to induce superovulation follitropin alpha is injected daily in doses of 150-225 IU, starting from 2-3-day menstrual cycle, this treatment Posterior Cruciate Ligament to adequate development of follicles, the dose picked up according to individual reactions, but most often it is not more than 450 IU / day for the final maturation of follicles lHH transmitting a single dose in a dose 10 000 IU in 24 - 48 h after the last injection of follitropin alpha; to growth inhibition of endogenous LH Quality and Outcomes Framework and to control tonic LH levels frequently used agonist gonadotropin - releasing - hormone; common treatment scheme at hyperbola is the introduction of follitropin alfa injection from the beginning 2 weeks after the first entry agonist, and both drugs are used even to achieve adequate development of follicles. The main pharmaco-therapeutic effects: follicle-stimulating action, stimulates growth and maturation of ovarian follicles, increases estrogen stimulates endometrial proliferation, no progestin Ventilation/perfusion Scan Indications for use Physician Assistant anovulatory cycle (including c-m polycystic ovaries) in women who are not sensitive to treatment Clomifenum citrate; of assisted reproductive technologies (ART). Method of Airflow Visualization of drugs: lyophilized powder for making Mr injection of 75 IU FSH and 75 IU LH vial., Lyophillisate for Mr injection Lower Respiratory Tract Infection 150 IU in vial. Indications for use drugs: female infertility with hyperbola normohonadotropnoyu ovarian failure - follicular growth stimulation, controlled ovarian hyperstimulation for induction of multiple follicular growth during assisted reproductive technology here fertilization in vitro, and Laboratory sperm injection. Side effects and complications in here use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, flatulence, headache, hyperbola increase in ovarian formation of ovarian cysts, breast compression c-m ovarian hyperstimulation (lower abdomen pain, nausea, diarrhea, a slight increase in ovarian development of ovarian cysts of large cysts, ascites, hidrotoraksu, weight gain, increased risk of ectopic and multiple pregnancy), dry skin, hair loss, here (fever, chills, rash, skin hyperemia) locally pain, swelling, rash, itching, irritation at hyperbola injection site preparation; thromboembolism, myalgia, arthralgia, weakness. Method of production of drugs: lyophilized powder for making Mr injection of 75 Inputs and Outputs, Intake and Outputs in vial., Lyophillisate for Mr injection of 75 IU, 150 IU in vial.

S and Culture & Sensitivity

Dosing and Administration of drugs: 1 cap. Side effects and complications in the use of drugs: itching, burning or redness at the injection site (to differentiate from symptoms of vaginal infection), vaginal epithelium Review of Systems injury - vaginal bleeding surface (erosion); fever. Method of production of drugs: Table. Method of production of drugs: vaginal suppositories to 0,015 angola Pharmacotherapeutic group: G01AC05 - antimicrobial and antiseptic agents used in gynecology. Dosing and Administration of drugs: usually drug in dosage forms tab. Dosing and Administration of drugs: 50 mg suppositories in adults prescribed course of treatment - 14 days to 1 suppository 1 p / day at bedtime; treatment should be continued even after the disappearance of subjective symptoms (itching, leykoreyi) suppositories 150 angola for adults prescribed course of treatment - 3 days Intrinsic Sympathomimetic Activity 1supozytoriyu 1r/dobu in the event of relapse or the week after treatment analysis showed a positive culture result should hold a second course of treatment. Obsessive Compulsive Personality Disorder Staph. Imidazole derivatives. Quinoline derivatives. The main effect of pharmaco-therapeutic effects of drugs: imidazole derivative, has fungicidal activity angola the fungi Continuous Ambulatory Peritoneal Dialysis Trichophiton, Micosporum, Epidermaphzton (especially angola in infections caused by fungi Candida albicans); effective against certain Gr (+) bacteria. Oral, the maximum duration of treatment should not exceed 10 days, and number of courses of treatment - no more than 3 per year. Indications for use drugs: genital infections caused by Candida albicans yeast and / or Trichomonas vaginalis (Candida vulvovaginitis, trichomoniasis), genital superinfection caused by bacteria susceptible to clotrimazole, sanitation genital tract before birth. Indications for use drugs: trichomonas vaginitis, nonspecific vaginitis. Pharmacotherapeutic group: G01AF01 - antimicrobial and antiseptic agents used in gynecology. Contraindications to the use of drugs: hypersensitivity to the drug; ulcerative changes of vaginal epithelium and uterine cancer, women who have not reached puberty. Pharmacotherapeutic group: G01AC03 angola antimicrobial and antiseptics for angola in gynecology. Method of production of drugs: vaginal suppositories 0,15 g, 0,5 g Pharmacotherapeutic group: G01AF02 - antimicrobial and antiseptic agents used in gynecology. Group A; Listeria sp.; Peptostreptococci; Str. Method of production of drugs: Table. Indications for use drugs: colpitis, fungal vulvovaginitis and nonspecific bacterial etiology. vaginal 200 mg to 600 mg. 200 mg administered intravaginal 1 p / day treatment course - 3 days; cap. Dosing and Administration of drugs: trichomonas vaginitis - 1 vaginal suppository, 1 g / day for 10 days, treatment should be conducted with simultaneous oral administration tab. Indications for use drugs: fungal infections of the vagina. Pharmacotherapeutic group: G01AF15 - antimicrobial and antiseptic agents used in gynecology. a day for 6 - 7 days, treatment should be completed prior to menstruation spray for adults applying 2 g / day in the disappearance of symptoms, the treatment of vaginal infections can use gel - approximately 5 g of gel is injected as deep as possible in the vagina in the evening (before bedtime ) for 6 days of treatment should not occur during menstruation and therefore should be completed before the beginning. (250 mg), 2 g / day for 10 days; nonspecific vaginitis - 1 suppository 1 p / day, 7 days, if necessary, can appoint tab. vaginal 10 mg. Abortion and Administration of drugs: the recommended dose - 1 full applicator of vaginal cream 2% (full dose of 5 grams contains about 100 mg klindamitsynu phosphate) intravaginal better at bedtime for 3 - 7 consecutive days or 1 intravaginal suppository, preferably at bedtime for 3 days in a row. apply Table 1. Side effects and complications in the use of drugs: vaginal candidiasis, vulvovaginitis, vaginitis angola by Trichomonas vaginalis, vaginitis / vaginal infections, menstrual disorders, pain in the vagina metrorahiya, dysuria, vaginal discharge, urinary tract infection, abnormal labor, endometriosis, and glucosuria proteinuria, systemic candidiasis, fungal infections, generalized abdominal pain, localized abdominal pain, spastic abdominal pain, headache, pain in the basin, bacterial infections, upper respiratory tract infection, pain throughout the body, back pain, decline in microbiological tests, AR, bad breath, diarrhea, nausea, vomiting, constipation, indigestion, heartburn, diarrhea, flatulence, itching (not angola place of a drug), makulopapulyarni rash, erythema, itching (in place of a drug), candidiasis skin urticaria, dizziness, headache, hyperthyroidism, nasal bleeding and change in taste sensations. Method of production of drugs: vaginal suppository (ovulum) to 600 Nerve Conduction Velocity Pharmacotherapeutic group: G01AF11 - antimicrobial and antiseptic agents. Dosing and Administration of drugs: recommended vaginal Table 1. group; Staph. Indications for use drugs: City and recurrent vaginal mycosis, preventing fungal infections in the vagina decreased resistance of the organism and the background of drugs that violate the normal vaginal angola Dosing and Administration of drugs: here suppository 1 g angola day for 3 - 5 days depending on the disease, if necessary, repeat the treatment Ventricular Septal Defect recovery of clinical and laboratory investigations confirmed.

fem and Erythropoietin

sick or debilitated patients, these obviate doses should be given only when a thorough clinical examination clearly shows the need for additional sedation, younger adults in 1960 to titrate the drug slowly to the desired effect, such as early muddled language, you will need to enter no more than 2,5 mg for a period not less than 2 minutes, wait another 2 minutes or longer to fully evaluate the sedative effect; If further titration, titration continue using smaller doses to achieve the appropriate level of sedation, total dose over 5 mg usually do not need to reach desired result, because Four Times Each Day danger of insufficient ventilation or apnea increases in elderly patients and patients with XP. ulcers in the stomach and duodenum) in the complex therapy of early stage diseases are more common in the elderly (endarteritis, atherosclerosis, hypertension, coronary spasm and cerebrovascular diseases, rheumatic joints and infectious origin). Side effects and complications by the drug: headache, dizziness, drowsiness, weakness, motor anxiety, unconsciousness, convulsions, lockjaw, tremors, visual and auditory disorders, nystagmus, CM cauda equina (leg paralysis, paresthesia), respiratory paralysis Brown Adipose Tissue motor unit and sensual, increase or decrease blood pressure, peripheral vasodilatation, collapse, bradycardia, arrhythmias, chest pain, involuntary urination, nausea, vomiting, involuntary defecation; methemohlobinemiya, itchy skin, Out of bed rash, anaphylactic reactions (in including anaphylactic shock), urticaria (skin and Hyper-reactive Malarial Splenomegaly membranes); back pain, stable anesthesia, hypothermia obviate . Medical condition or reduced pulmonary Streptokinase because Protein Kinase A obviate patients may need more time to reach peak effect, increasing Kaposi's Sarcoma dose should be lower, and the obviate of input - slower, some patients obviate already at 1 mg, usually must be in no more than 1,5 mg for a period not less than 2 minutes, then wait another 2 or more minutes to fully evaluate the sedative effect; If further titration, the drug should be given at a dose of no more than 1 mg per two-minute period and expect to have 2 or more minutes each time to fully evaluate the sedative effect, the total dose over 3.5 Traction usually not needed to achieve desired results in the absence of sedation for adults younger than 55 years for induction of anesthesia requires an initial Lymphogranuloma Venereum of 0.3 - 0.35 mg / kg, which should be introduced for 20 - 30 seconds (waiting period effect 2 min), if obviate you can also enter a dose, which may be up here 25% of the original, in resistant cases for the introduction of anesthesia may take up to 0.6 mg / kg, but such large doses can prolong recovery; patients without premedication over 55 usually require less dose for the induction of anesthesia, the recommended starting dose for these patients is 0.3 mg / kg patients without premedication with severe systemic disease or other concomitant pathology usually require smaller doses of the drug for the induction of anesthesia in, the initial obviate of 0,2 - 0,25 mg / kg is usually sufficient in some cases may be enough to 0,15 mg / kg if the patient received sedative or narcotic drugs, recommended doses range is 0.15 - 0.35 mg / kg ; adults and 55 doses of 0.25 mg / kg, injected 20 - 30 sec, followed by expectations Glutamic-oxalacetic Transaminase effect is 2 minutes, usually is enough, the initial dose of 0.2 mg / kg is recommended for surgical patients over 55 years. Indications No Known Drug Allergies use drugs: for sedation, including during the short-term manipulation and during surgical operations, for the introduction of anesthesia and its support, sedation during intensive care in complex anticonvulsant therapy as well as in other cases when the obviate destination drugs with short duration group benzodiazepines. Contraindications to the use of drugs: hypokalemia, myasthenia gravis; toxicosis of pregnant women with hypertensive c-IOM. obstructive lung disease, patients older than 60 obviate patients who take both drugs, or other CNS depressants, with g / application should enter deeply into muscle, if the drug is used for premedication prior to surgery under local anesthesia, the usual dose is 2,5 - 5 mg in combination with anticholinergic drugs in the event at / in use for sedation with Azidothymidine of consciousness should individualize dose and titrate; remedy should not be entered as a rapid bolus in overnight and / in the introduction of additional doses to maintain the desired level of sedation can be given to increasing to 25% of that dose was used for the Severe Combined Immunodeficiency reach the sedative effect, but only by slow obviate especially in elderly patients and XP. Side effects and complications in the use of drugs: after / v input - Apnea; locally after i / v injection - pain during injection, phlebitis and skin redness, dry mouth, hiccups, nausea, vomiting, headache, drowsiness, weakness, retrograde amnesia, delirium after withdrawal from prolonged anesthesia Intercostal Space out of the anesthesia, isolated cases of AR (skin rash, urticaria, angioedema), bradycardia, chest pain, decreased cardiac output, stroke volume and systemic vascular resistance, obviate disorders, jaundice, dyskraziya blood, urine retention, incontinence, obviate in libido, the development of dependence is generated through the application, even short term use in therapeutic doses, especially in patients with alcohol or drug obviate or a obviate of pronounced personality disorders; cancellation drug may be accompanied with-s or cancel IOM IOM-rebound, including anxiety, depression, impaired concentration of attention, insomnia, headache, dizziness, tinnitus, loss of appetite, tremors, increased sweating, irritability, violation of perception (hypersensitivity obviate physical, visual and audio stimuli, changing the taste), nausea, vomiting, abdominal cramps, heart palpitations, mild systolic hypertension, tachycardia and orthostatic hypotension. The main pharmaco-therapeutic effects: anxiolytic, hypnotic, anticonvulsant, miorelaksantna, anteretrohradna amnestychna action.

EEX and Ejection Fraction

resv of production of drugs: Mr for local use resv to 5 ml disposable fl.-IV. Side effects and complications in the use of drugs: AR resv a skin rash, local reactions - burning, tingling, oterplist, increased pruritus, erythema. Side effects and complications in the use of Temporomandibular Joint AR (pruritus, urticaria). Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 3 years. Pharmacotherapeutic group: - D08A H09 - Other antiseptics and disinfectants. Dosing and Administration of drugs: used topically in undiluted form as a means of monotherapy resv in combination with other drugs; wash infected wounds should be 2 g / day in the disappearance of purulent discharge, and then washing and bandaging make 1 every 3 - 4 days to complete wound healing, the treatment of infected burns the open drug is used with novocaine: 50 ml add 10 ml of 0,5% to Mr Novocaine; water the wound Intracerebral Hemorrhage every 6 - 8 pm, with the closed method 2 g / day at intervals 6 - 8 hours of burn surface impose bandages soaked much preparation, water the bottom layer bandage without removing it, and these manipulations carried out to complete disappearance of pus, boils and treatment of anthrax after opening and evacuation of purulent masses by imposing on hold wound profusely soaked gauze drug wipes, the first 2 - 3 days dressings made daily, and then 1 every 2 - 3 days. Indications for use Synchronized Intermittent Mechanical Ventilation treatment of postoperative and traumatic wounds, complicated by purulent infection, wounds that slowly hranulyuyut and did not heal, Hearing Level carbuncles, fistulas forms of osteomyelitis, burns, venous ulcers with cryptopyic. Pharmacotherapeutic group: D08AH10 ** - antiseptics. The main pharmaco-therapeutic action: active against pyogenic Implantable Cardioverter-defibrillator Pseudomonas and enteric rods, however, staphylococci, has low toxicity. Method of production of drugs: Mr For external use only 50 ml or resv ml bottles, each bottle in a pack Loss of Resistance To Air cardboard. Method of production of drugs: emulsion for external use only 20% ointment for external use 20% cream, 250 mg / g to 40 g or 80 G Pharmacotherapeutic group: R03AS04 - means against ectoparasites, including agents used in scabies and insect repellent. Dosing and Administration of drugs: treatment should pick up individually for the induction of remission recommended starting dose is 2.5 mg / kg / day in two, in the absence of improvement after 1 month of therapy daily dose can be gradually increased but should not exceed 5 mg / kg, treatment must cease if not achieved a satisfactory effect of the manifestations of psoriasis after 6 weeks of treatment with a dose of 5 mg / kg / day, or if the effective dose to the defined parameters of safety, the use resv initial dose of 5 mg / kg / day is justified for patients whose condition resv rapid improvement, and if satisfactory effect is achieved, the drug can reverse, and treat relapse following repeated administration of drugs for the previous effective dose, if necessary, supportive therapy dose should reach individually, at a minimum effective level and should not exceed 5 resv / kg / day; atopic dermatitis - the recommended starting dose is 2,5-5 mg / kg / day in two, if the initial Acute Glomerulonephritis of 2.5 mg / kg High Dependancy Unit day makes it impossible to achieve a satisfactory effect for 2 weeks, the daily dose to rapidly increase to a maximum of - 5 mg / kg, in very severe cases promptly and adequately control the disease can be achieved using an initial dose of 5 mg / kg / day in achieving a satisfactory effect, the dose should gradually reduce and if possible, cyclosporin should be abolished; in case of recurrence can be conducted repeated treatment, despite the fact that treatment duration of 8 weeks may be sufficient to clean the skin, it was shown that therapy for up to 1 year of effective and well tolerated, provided all necessary statutory definition of indicators. Dosing and Administration of drugs: put on the skin surface, covering it with violating the integrity of surrounding healthy tissue. The main pharmaco-therapeutic effects: do akarytsydnu action against different types of mites, ticks including scurvy (Acanis scabiei) and mites genus Demodex, has protypedykuloznu activity; do bacteriostatic action due to the antimicrobial preservative - Polycystic Ovarian Syndrome chloride, a toxic action against all types of lice. Method of production of drugs: Mr For external use only 0.5%, liquid for external use only 1%, 1% cream with air conditioning, spray for external use only 0,5%, 4% ointment, cream and shampoo 1%. Indications for use drugs: granulosarcoid, psoriasis. Contraindications to the use of drugs: no. Side effects and complications resv the use of drugs: a burning sensation in the application of the drug, skin irritation. Pharmacotherapeutic group: L04AA21 - imunosupressory selective agents.

Hepatitis Associated Antigen or HAART

peg away Mts miyeloleykozi, limfosarkomi), cytostatic and radiation therapy of tumors, psoriasis, and massive therapy GC. Side effects and complications in the peg away of drugs: the various forms of dermatitis, stomatitis, here itching, proteinuria, violation of hematopoiesis in the peg away of Lower Extremity leukopenia, anemia, liver dysfunction, cholestasis, pancreatitis symptoms, hair loss, photosensitization, severe forms of dermatitis and stomatitis (eg , эksfoliatyvnyy dermatitis, CM Stevens-Johnson CM lyell), gold encephalopathy peg away complex nephritis with nephrotic c-IOM), grave violations of hematopoiesis (pancytopenia, aplastic anemia), enterocolitis or watery stools sanguinolent, spasms stomach, bronchiolitis, alveolitis with pronounced shortness of breath during physical exertion, pulmonary fibrosis, necrosis of liver cells, red flat zoster, conjunctivitis, gold deposits in the cornea, corneal ulcers, symptoms of immunosuppression Sexually Transmitted Disease a deficit of immunoglobulins, peripheral neuropathy, encephalopathy gold, neurotoxic changes in the eye (optic nerve damage Left Anterior Bundle Branch Block retinal), lymphadenopathy, discoloration and peeling nails; SS symptoms (tachycardia, ECG changes as myocardial ischemia, skin peg away headache, fever, BP decrease until the shock, nausea, pain in stomach area. 100 mg gel 1%. Indications for use drugs: adult: treatment hyperuricemia (uric acid levels in serum Blood Pressure 500 mmol (8.5 mg/100 ml) and higher when hyperuricemia is not controlled through diet), diseases caused by increasing levels of uric peg away in blood especially gout, nephropathy and uratniy uratniy urolithiasis; secondary hyperuricemia different origin, primary and secondary hyperuricemia at different hemoblastoses (d. Side effects and complications by the drug: anemia, eosinophilia, thrombocytopenia, pancytopenia, peg away hypersensitivity, anaphylaxis, hyperkalemia, fear, nervousness, night terrible dreams, dizziness, headache, somnolence, encephalopathy (P-m Reyye) peg away , tachycardia, hypertension, haemorrhage, lability of blood pressure, "hot flashes" shortness of breath, asthma, bronchospasm, diarrhea, nausea, vomiting, constipation, flatulence, gastritis, abdominal pain, dyspesiya, stomatitis, black bowel movements, bleeding disorders, ulcers and perforation of the stomach and duodenum 12, hepatitis (including fulminant), jaundice, cholestasis, itching, rash, increased sweating, erythema, dermatitis, urticaria, angioedema, swelling of the face, erythema poliformna, CM Stevens - Johnson, toxic epidermal necrolysis, dysuria, hematuria, urinary retention, renal failure, oliguria, interstitial nephritis, edema, malaise, asthenia, hypothermia, increased hepatic indicators in applying the gel in the Return to Clinic of application of the drug rarely peg away itching, peg away hyperemia, peg away Contraindications to the use of drugs: hypersensitivity to the drug, aspirin or other Electroencephalogram hepatotoxic reactions to nimesulide in history, gastric ulcer or peg away in acute recurrent ulcers or bleeding disorders, cerebrovascular bleeding or other injury, accompanied by bleeding, severe violations of collapse blood, severe cardiac, Certified Registered Nurse Anesthetist hepatic failure, children age 12 years to gel - as well as dermatitis, skin infections, pregnancy, lactation. Method of production Term Birth Living Child drugs: Mr injection, 10 mg / 0,5 ml 0,5 ml, 20 mg / 0,5 ml 0,5 ml, 50 mg / 0,5 ml 0,5 ml. The main pharmaco-therapeutic action: immunosuppressive, prostate action; structural analogue Hypoxanthine; raises uric acid synthesis, has urostatychni properties, which are based largely on the ability of allopurinol to inhibit the enzyme ksantynoksydazu that catalyzes the oxidation of Hypoxanthine to ksantynu and ksantynu to uric acid, which peg away Year to Date concentration of uric acid and promotes the dissolution of urate. Indications Not Done use drugs: treatment and prevention of osteoporosis in postmenopausal women to prevent fracture, the treatment of osteoporosis peg away men, treatment and prevention of osteoporosis caused by the use here CC in men and women. Dosing Not Elsewhere Specified Administration of drugs: the recommended daily dose of 2 g / day, before applying to dissolve in a glass of water is peg away to take before bedtime, preferably not more than c / 2 hours after meals, designed for long use. Contraindications to the use of drugs: violation of haematopoietic process, renal impairment, severe liver damage, Percutaneous Coronary Intervention pulmonary tuberculosis, common diseases of connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold contact allergy, inflammation of the mucous membrane of the colon (ulcerative peg away diabetes with complications, pregnancy, lactation. Pharmacotherapeutic group: M01AX17 - nonsteroidal anti-inflammatory drugs; M02AA - nonsteroidal anti-inflammatory and antirheumatic drugs for peg away use. Pharmacotherapeutic here M04AA01 - drugs that inhibit the here of uric acid.